2020
DOI: 10.1158/1078-0432.ccr-19-1467
|View full text |Cite
|
Sign up to set email alerts
|

Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer

Abstract: Purpose: Molecular subtyping for pancreatic cancer has made substantial progress in recent years, facilitating the optimization of existing therapeutic approaches to improve clinical outcomes in pancreatic cancer. With advances in treatment combinations and choices, it is becoming increasingly important to determine ways to place patients on the best therapies upfront. While various molecular subtyping systems for pancreatic cancer have been proposed, consensus regarding proposed subtypes, as well as their rel… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
174
2
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 139 publications
(185 citation statements)
references
References 24 publications
3
174
2
1
Order By: Relevance
“…Furthermore, any definition of PDAC subtypes may suffer from label noise, and it cannot be conclusively resolved at this point, how robustly the applied histopathological methodology can represent the transcriptome-based molecular phenotype [22]. Nevertheless, the highly significant separation of survival in the unclassifiable tumor subgroup observed in our study seems to support the binary classification of PDAC subtypes as recently proposed [27].…”
Section: Discussionmentioning
confidence: 40%
“…Furthermore, any definition of PDAC subtypes may suffer from label noise, and it cannot be conclusively resolved at this point, how robustly the applied histopathological methodology can represent the transcriptome-based molecular phenotype [22]. Nevertheless, the highly significant separation of survival in the unclassifiable tumor subgroup observed in our study seems to support the binary classification of PDAC subtypes as recently proposed [27].…”
Section: Discussionmentioning
confidence: 40%
“…These include a "basal-like" (or squamous) subtype, which is poorly differentiated and carries a worse prognosis when compared with the better-differentiated "classical" (or progenitor) subtype (4,7,10). Basal-like and classical subtypes have been shown to share features of the squamous and progenitor subtypes, respectively, as defined by an independent PDAC classification system (5,11,12), which also can predict response to chemotherapy (6,(13)(14)(15). In addition, the basal-like subtype is associated with the activation of genes involved in the epithelial-mesenchymal transition (EMT), activation of the transcription factors MYC and TP63, and downregulation of endodermal identity markers, such as HNF4A and GATA6, whose expression are therefore hallmarks of the classical subtype (4,6,7).…”
mentioning
confidence: 99%
“…PDX were ranked into five different histological classes by two blinded expert pathologists ranging from the less differentiated PDX (class I), which is associated with the most aggressive phenotype, to the most differentiated PDX (class V; Figure S1). The here described five histological classes of PDX strongly correlates with the expression of genes defining the already described molecular subtypes [6][7][8][9] as higher expression of genes linked to the classical PDAC subtype is correlated with increased differentiation of PDX samples, combined with lower expression of genes linked to basal-like subtype (Figure 1a and Figure S1). Interestingly, the variation in the expression of the classical genes towards the basal-like genes vary gradually from the more differentiate to the less differentiate histological classes respectively.…”
Section: Using Pdx To Define the Molecular Diversity Of Pdacmentioning
confidence: 57%
“…Several studies using only resectable tumors show molecular diversity of the epithelial compartment of PDAC is associated with tumor aggressiveness and patient prognosis [7,8,14]. Our next goal was to determine if the PAMG could be predictive in all PDAC tumors.…”
Section: The Pamg Is Associated To Tumor Aggressivenessmentioning
confidence: 99%
See 1 more Smart Citation